diabetes – Page 2 – media

Predict Your Diabetes Risk Levels by Checking Your Partner’s BMI

According to the WHO statistical report, around 1.5 million deaths are caused due to diabetes worldwide. With these statistics in mind, a research team from the University of Copenhagen and Aarhus University in Denmark conducted research on diabetes patients.
- Source: India Times
- 688
- June 27, 2018
BMI diabetes Researches
FDA Approval for Eversense – Continuous Glucose Monitoring System

The FDA has finally approved to market the implantable continuous glucose monitoring system named Eversense, from Senseonics, in the United States.
- Source: MobiHealthNews
- 962
- June 27, 2018
diabetes digital health mHealth New Approvals
Tuberculosis Vaccine (BCG) Can Treat Type 1 Diabetes

Administration of two doses of BCG with a duration of four weeks apart can normalize the blood sugar levels for up to eight years. Tumor necrosis factor (TNF) is a protein that eliminates improper immune cells that destroy pancreatic islets, involved in immune production. But the administration of BCG can ultimately regulate T cells and boost TNF production.
- Source: FierceBiotech
- 602
- June 25, 2018
diabetes Researches tuberculosis
Glucose Monitoring App Through Medtronic-Nutrino Partnership

Medtronic, a medical technology company, and AI-powered personalized nutrition platform Nutrino, have entered into a partnership. The FoodPrint Report technology of Nutrino is slated to be integrated into the iPro2myLog app of Medtronic, a platform which offers continuous glucose monitor enabling users to gain critical insights into their glucose levels.
- Source: MobiHealthNews
- 736
- June 21, 2018
AI Company Insight diabetes
New Anti-Diabetes Drug Aids In Weight Loss

U.S. Food and Drug Administration officially approved the weekly injection of semaglutide under the brand name of Ozempic. This therapy along with healthy diet and exercise would improve glycemic control in adults with type 2 diabetes. The side effects of semaglutide was found to be mild or moderate nausea.
- Source: India Times
- 758
- June 14, 2018
diabetes New Approvals obesity
Glooko Launched Advanced Version for Diabetes Management

The newly launched site will also provide details on the effect that food intake, exercise, and medication can have on control glucose levels along with color-coded graph and charts which are focused at usability, bolus tracking features, amplified insulin pump reports, and statistics.
- Source: MobiHealthNews
- 724
- June 12, 2018
diabetes mHealth New Approvals
Discovery of Fat Burner Hormone

It was great news in the field of medicine when geneticists from University of California, Los Angeles (UCLA) created a novel technique to hunt for natural hormones that would enhance cell communication to play a major role in treating obesity, diabetes and cardiovascular diseases. Scientists discovered two hormones called "notum" and "lipocalin-5", which would aid in the fat burning process. Lipocalin-5 also enhances metabolism and absorption of dietary nutrients by reducing the risk of diabetes and obesity.
- Source: medicalxpress
- 597
- June 8, 2018
diabetes obesity Researches
Smartphone apps to help Queensland mothers from gestational diabetes

Diabetes Australia's (the third oldest diabetes association in the world) latest figures show that over 200,000 women have suffered gestational diabetes during the last 10 years and is expected to exceed 500,000 within the next decade. Gestational diabetes can be fatal if untreated and could likely lead to overweight babies, premature births, as well as PreEclampsia.
- Source: Ddu
- 864
- May 11, 2018
diabetes pregnancy Researches
Artificial pancreas is a safe and effective treatment for type 1 diabetes

Use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment, finds a review of the available evidence published by The BMJ today.
- Source: MedicalXpress
- 628
- April 19, 2018
diabetes digital health Researches
Lilly, Sigilon Partner on Encapsulated Cell Therapies for Diabetes

Eli Lilly and Company and Sigilon Therapeutics, a privately held biopharmaceutical company, announced a global collaboration to develop encapsulated cell therapies for potentially treating Type 1 diabetes. The deal is worth up to $473 million. Sigilon is focused on discovering and developing “living therapeutics” using its Afibromer technology product platform.
- Source: Sigilon Therapeutics
- 505
- April 10, 2018
diabetes Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.